Reaktion #3409

ord-d8f9af624c254aa681fb4cd3472eb869

Reaktionsgleichung

Brc1cncc(Br)c1
3,5-dibromopyridine
[Li][C](C)(C)C
t-BuLi
C1CC2=[N+](C1)CCC2.[O-][Cl+3]([O-])([O-])[O-]
1,2,3,5,6,7-hexahydropyrrolizinium perchlorate
Brc1cncc(C23CCCN2CCC3)c1
oil
Ausbeute 28.4%
Brc1cncc(C23CCCN2CCC3)c1
7a-(5-bromo-3-pyridinyl)-hexahydro-1H-pyrrolizine
Ausbeute 28.4%

Lösungsmittel

Reaktionsbedingungen

Temperatur
-95°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturwarm to -10° C.
  2. 2
    workup.STIRRINGstir for 2 hours
  3. 3
    SonstigeThe cold bath was removed
  4. 4
    workup.ADDITION2N HCl was added
  5. 5
    Sonstigethe phases were separated
  6. 6
    Extraktionextracted with CH2Cl2 (2×)
  7. 7
    Trocknendried (MgSO4)
  8. 8
    Einengenconcentrated
  9. 9
    Sonstigethe residue was chromatographed (silica gel; CHCl3 /MeOH, 98:2)

Vorschrift

3,5-dibromopyridine (500 mg, 2.11 mmol, Aldrich) was dissolved in Et2 O and cooled to -95° C. A solution of 2.5M t-BuLi (1.7M in pentane, 2.7 mL, 4.64 mmol) in pentane was added dropwise. 1,2,3,5,6,7-hexahydropyrrolizinium perchlorate (663 mg, 3.2 mmol) was added, and the reaction mixture was allowed to stir and warm to -10° C. and stir for 2 hours. The cold bath was removed, 2N HCl was added, and the phases were separated. The aqueous phase was basified with 15% NaOH and extracted with CH2Cl2 (2×). The CH2 Cl2 fractions were combined, dried (MgSO4) and concentrated, and the residue was chromatographed (silica gel; CHCl3 /MeOH, 98:2) to afford a clear oil (160 mg, 28%): 1H NMR (CDCl3, 300 MHz) 67 1.57-1.71 (m, 2H), 1.79-2.04 (m, 6H), 2.62-2.73 (m, 2H), 3.11-3.20 (m, 2H), 8.04 (dd, J=2.0, 2.0 Hz, 1H), 8.46 (d, J=2.0 Hz, 1H), 8.58 (d, J=2.0 Hz, 1H); MS (CI/NH3) m/z: 267/269 (M+H)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05733912uspto-grants-1998_03